This HTML5 document contains 66 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n11http://linked.opendata.cz/resource/drugbank/drug/DB01600/identifier/chemspider/
n10http://linked.opendata.cz/resource/mesh/concept/
n15http://linked.opendata.cz/resource/drugbank/drug/DB01600/identifier/chebi/
n5http://linked.opendata.cz/resource/drugbank/drug/DB01600/identifier/wikipedia/
n21http://linked.opendata.cz/resource/drugbank/drug/DB01600/identifier/pharmgkb/
n14http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n16http://linked.opendata.cz/resource/drugbank/drug/DB01600/identifier/pubchem-compound/
n18http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n17http://linked.opendata.cz/resource/drugbank/drug/DB01600/identifier/pubchem-substance/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://linked.opendata.cz/resource/drugbank/medicinal-product/
n9http://linked.opendata.cz/ontology/mesh/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n12http://linked.opendata.cz/resource/drugbank/drug/DB01600/identifier/drugbank/
n6http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n20http://linked.opendata.cz/resource/atc/
n19http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB01600
rdf:type
n3:Drug
n3:description
Tiaprofenic acid is a non-steroidal anti-inflammatory drug of the arylpropionic acid (profen) class, used to treat pain, especially arthritic pain.
n3:group
approved
n3:halfLife
1.5-2.5 hours
n3:indication
Tiaprofenic acid is used to treat pain, especially arthritic pain.
owl:sameAs
n14:DB01600 n18:DB01600
dcterms:title
Tiaprofenic acid
adms:identifier
n5:Tiaprofenic_acid n11:5269 n12:DB01600 n15:32221 n16:5468 n17:46504590 n21:PA164764503
n3:mechanismOfAction
Tiaprofenic acid belongs to a group of medicines called non-steroidal anti-inflammatory drugs (NSAIDs). It works by blocking the production of a chemical (prostaglandin) which the body produces in response to injury or certain diseases. This prostaglandin would otherwise go on to cause swelling, pain and inflammation.
n3:synonym
2-(5-Benzyl-2-thienyl)propionsaeure Tiaprofensaeure 2-(5-Benzoyl-thiophen-2-yl)-propionic acid alpha-Methyl-5-benzoyl-2-thienylacetic acid Acido tiaprofenico Acidum tiaprofenicum 5-Benzoyl-alpha-methyl-2-thiopheneacetic acid Tiaprofensäure 5-Benzoyl-alpha-methylthiophene-2-acetic acid Acide tiaprofenique
n3:foodInteraction
Avoid alcohol. Take with food.
n9:hasConcept
n10:M0075913
n3:IUPAC-Name
n6:271B5A94-363D-11E5-9242-09173F13E4C5
n3:InChI
n6:271B5A9A-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n6:271B5A99-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n6:271B5A96-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n6:271B5A97-363D-11E5-9242-09173F13E4C5
n3:SMILES
n6:271B5A98-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n6:271B5A92-363D-11E5-9242-09173F13E4C5
n3:logP
n6:271B5A90-363D-11E5-9242-09173F13E4C5 n6:271B5A93-363D-11E5-9242-09173F13E4C5
n3:logS
n6:271B5A91-363D-11E5-9242-09173F13E4C5
n19:hasATCCode
n20:M01AE11
n3:H-Bond-Acceptor-Count
n6:271B5AA0-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n6:271B5AA1-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n6:271B5A9B-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n6:271B5A9C-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n6:271B5A9E-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n6:271B5A9D-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n6:271B5A9F-363D-11E5-9242-09173F13E4C5
n3:absorption
Bioavailability is 90% following oral administration.
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
33005-95-7
n3:category
n3:containedIn
n8:271B5A8F-363D-11E5-9242-09173F13E4C5 n8:271B5A8D-363D-11E5-9242-09173F13E4C5 n8:271B5A8E-363D-11E5-9242-09173F13E4C5 n8:271B5A8C-363D-11E5-9242-09173F13E4C5 n8:271B5A8B-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n6:271B5AA6-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n6:271B5AA8-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n6:271B5AA9-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n6:271B5AAA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n6:271B5AA5-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n6:271B5AA4-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n6:271B5AA7-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n6:271B5A95-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n6:271B5AA2-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n6:271B5AA3-363D-11E5-9242-09173F13E4C5